| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Uniqure N.V. (QURE) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. QURE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 150.4K | $6.96M | - | |
| Other | 133.2K | $6.17M | -5,237 | |
| CFO | 63.9K | $2.96M | - | |
| Dir | 53.3K | $2.47M | -10,000 | |
| Dir | 40.1K | $1.86M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 28, 2019 | Kaye Jack53 | Director | Sell | 1,210 | $31.31 | $37,885.10 | -7.5% | |
| Jan 28, 2019 | Balachandran Madhavan52 | Director | Sell | 1,210 | $31.31 | $37,885.10 | -15.1% | |
| Jan 28, 2019 | Soteropoulos Paula75 | Director | Sell | 1,210 | $31.32 | $37,897.20 | -5.7% | |
| Jan 28, 2019 | Schaffer David86 | Director | Sell | 1,210 | $31.31 | $37,885.10 | -2.6% | |
| Jan 28, 2019 | Astley-Sparke Philip47 | Director | Sell | 1,210 | $31.32 | $37,897.20 | -4.6% | |
| Jan 28, 2019 | Springhorn Jeremy P.52 | Director | Sell | 1,210 | $31.32 | $37,897.20 | -15.1% | |
| Jan 17, 2019 | Schaffer David86 | Director | Sell | 7,500 | $30.71 | $230,325.00 | -14.6% | |
| Jan 3, 2019 | Klemt Christian58 | Chief Accounting Officer | Sell | 5,739 | $27.91 | $160,175.49 | -12.5% | |
| Dec 3, 2018 | Astley-Sparke Philip47 | Director | Sell | 5,000 | $30.39 | $151,950.00 | -17.7% | |
| Jun 6, 2018 | Zelenkofske Steven | Chief Medical Officer | Sell | 23,929 | $37.14 | $888,723.06 | -13.0% |